Lenalidomide
【Product name】Revlimid
[English common name]Lenalidomide
[Chinese common name]Lenalidomide
[English name]Lenalidomide
[Chinese other name]Laminamide
[Indications] This product is combined with dexamethasone to treat at least one therapy.Multiple myelomaAdult patient.
【Dosage】
Treatment medication must be initiated and provided under the supervision of a physician with multiple myeloma treatment experience.
If the patient's absolute neutrophil count (ANC) is <1.0×109/L, or the patient's platelet count is <50×109/L, and the proportion of plasma cells in the bone marrow is less than 50%, or the patient's platelets Counting <30×109/L, and the ratio of plasma cells to nucleated cells in the bone marrow is >50%, then the treatment of this product should not be started.
Recommended dose
The recommended starting dose for this product is 25mg. On the 1st to 21st days of each repeated 28-day cycle, 25 mg of this product was orally administered daily until the disease progressed. The recommended dose of dexamethasone is oral administration of 40 mg of dexamethasone on days 1, 8, 15, and 22 of the 28-day treatment cycle.
[Storage] Store at 20 ° C – 25 ° C (68 ° F – 77 ° F); allow for offset 15 ° C – 30 ° C (59 ° F – 86 ° F).
[Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
各国版本
中文学术
《中国多发性骨髓瘤诊治指南(2015年修订)》治疗部分江苏解读
来那度胺、三氧化二砷及维生素C治疗复发_难治性多发性骨髓瘤的疗效分析
来那度胺、环磷酰胺联合地塞米松方案化疗治疗多发性骨髓瘤的临床效果及安全性分析
来那度胺联合VAD化疗方案…多发性骨髓瘤的疗效和安全性_杨毅
来那度胺联合小剂量地塞米松治疗复发难治性多发性骨髓瘤的临床观察
来那度胺联合环磷酰胺、低剂量地塞米松治疗多发性骨髓瘤临床观察
来那度胺联合硼替佐米和地塞…治疗多发性骨髓瘤的疗效观察_王珂
硼替佐米联合来那度胺和地塞米松治疗新诊断多发性骨髓瘤疗效及安全性分析